COVID-19 vaccine: Rich countries might gain, poor ones might suffer

As trials for vaccine candidates continue, the question of which countries will gain access to it has become pressing. Low-income countries are likely to suffer in this regard

December 06, 2020 by Newsclick

Multiple vaccine candidates for COVID-19 are looking promising and performing well in trials. However, just a few rich countries have already either booked or bought most of the doses of these vaccines that will be manufactured the next year. Low and middle-income countries are at the bottom of the queue to receive vaccine doses.

× To Subscribe